RxDoctor Payments Data

David Dickens

Pediatric Hematology-Oncology · Iowa City, IANPI 1720058092

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $3,712 of the $4,102 with a category attached, or 90.5%. Y-mabs Therapeutics, Inc. accounts for 63.4% of it on its own, with 1 other manufacturer making up the rest.

$4,102in general payments, 2019–2025

Across 7 payments — averaging $586.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Y-mabs Therapeutics, Inc.$3K
  • Amgen$2K
$579,308in research payments, 2019–2025

Across 50 payments — averaging $11,586 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Jazz Pharmaceuticals Inc.$357K
  • GSK$91K
  • Syndax Pharmaceuticals, Inc.$58K
  • AbbVie$44K
  • Merck$17K
  • Incyte Corporation$6K
  • plus $7K from 3 others

What the payments were for

  • Consulting fees$3,71290%
  • Food & beverage$39010%

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Y-mabs Therapeutics, Inc.6$2,602
Amgen1$1,500

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,102 in reported general payments places this provider in the 85th percentile of 21 pediatric hematology-oncology providers in Iowa.

See all pediatric hematology-oncology providers in Iowa

Other pediatric hematology-oncology in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →